Could a bone marrow transplant free kidney patients from lifelong drugs?
NCT ID NCT05900401
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a bone marrow transplant, given after a kidney transplant, can help the body accept the new kidney without needing lifelong anti-rejection drugs. About 20 adults aged 18-65 who already have a well-functioning kidney transplant will receive an investigational medication and other treatments to protect the kidney. The goal is to see if this approach is safe and can lead to long-term kidney tolerance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIMERA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which emergency dialysis saves more lives? a new study investigates
- Aging kidneys under the microscope: could a simple test predict failure?
- Can a vaccine shield transplant patients from shingles?
- Can dialysis change how a kidney drug works? a trial investigates
- Can a single drug dose forecast transplant kidney health?
- Virtual nature escape could calm dialysis patients